KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Share-based Compensation (2016 - 2025)

CareDx's Share-based Compensation history spans 13 years, with the latest figure at $8.1 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 51.0% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $34.9 million, down 47.5%, while the annual FY2025 figure was $34.9 million, 47.5% down from the prior year.
  • Share-based Compensation for Q4 2025 was $8.1 million at CareDx, down from $8.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $16.9 million in Q3 2024 and bottomed at $6.5 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $10.9 million (2021), against an average of $11.6 million.
  • The largest annual shift saw Share-based Compensation soared 65.76% in 2024 before it crashed 51.0% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $9.5 million in 2021, then increased by 27.67% to $12.1 million in 2022, then dropped by 17.85% to $10.0 million in 2023, then skyrocketed by 65.76% to $16.5 million in 2024, then plummeted by 51.0% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Share-based Compensation are $8.1 million (Q4 2025), $8.4 million (Q3 2025), and $9.4 million (Q2 2025).